Retinal Abnormalities and Blue Skin from Antiseizure Drug

• Autores: Diane S. Aschenbrenner
• Localización: American Journal of Nursing, ISSN 0002-936X, Vol. 113, Nº. 8, 2013, págs. 23-24
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • * The Food and Drug Administration has issued a warning that some patients taking ezogabine (Potiga) to control seizures have developed pigment changes in the retina or blueness in their skin.

    * These adverse effects are becoming evident after prolonged use of ezogabine.